Close Menu
Home › Palmetto Issues Draft Local Coverage Determination for Natera Kidney Transplant Test

Palmetto Issues Draft Local Coverage Determination for Natera Kidney Transplant Test

Mar 28, 2019
|
staff reporter

NEW YORK (GenomeWeb) – Medicare contractor Palmetto GBA has issued a draft local coverage determination for Natera's cell-free DNA-based kidney transplantation rejection test, Prospera, the company said today.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Dec
19
Featured Webinar

Evolution of Tumor Profiling in a Clinical Lab: Moving toward Comprehensive Genomic Profiling

Sponsored by
Qiagen

This webinar will provide a first-hand look at how a clinical lab evolved its tumor profiling workflow from a targeted panel approach toward comprehensive genomic profiling.  

Jan
28
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

What's Popular?

In Cancer

  1. NCCN Updates Genetic Testing Guidelines for Assessing Breast, Ovarian, Pancreatic Cancer Risk

  2. FDA Approves Foundation Medicine CDx for Novartis Breast Cancer Drug Piqray

  3. Illumina, ArcherDx Expand Partnership on NGS IVD Tests

  4. Ambry Genetics, Caris Life Sciences Partner on Cancer Genetic Testing

  5. Veracyte Exclusively Licenses NanoString Diagnostic Platform for Up to $60M

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.